Why Morgan Stanley likes Gilead's HIV prevention play
Morgan Stanley met privately with Gilead Sciences (GILD) leadership at its 2026 Global Healthcare Conference this month, and the feedback strengthened the bank’s positive view on the stock.
20 Sep 13:03 · The Fresno Bee